Elgan Pharma and Chiesi Group Announce First Participating Infants Dosed in Phase 3 Study of ELGN-2112 for Treatment of Intestinal Malabsorption in Preterm Infants
ELGN-2112 has the potential to be the first innovative therapeutic treatment for intestinal malabsorption in preterm neonates Elgan Pharma and Chiesi Farmaceutici... Read more.
Waterdrop Inc. Announces First Quarter 2025 Unaudited Financial Results, Net profit rises 34.2% year-on-year
BEIJING, June 5, 2025 /PRNewswire/ — On June 5, 2025, Waterdrop Inc. (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare services... Read more.
CIBS2026 Sales Officially Launched: The Future Thrives on Water Boosting Consumption to Empower Industries
SHANGHAI, June 5, 2025 /PRNewswire/ — Facing the transformation of the shipping industry under the “dual carbon” goals, China Shanghai International... Read more.
Congressmen Evans, Edwards Introduce Bill to Build Out National Skills-Training System
The LEON Act, supported by OIC of America, is designed to build pathways out of poverty and solve our long-term labor shortage. WASHINGTON, June 5, 2025 /PRNewswire/... Read more.
Two thirds of hiring managers are concerned about the use of GenAI to cheat on recruitment assessments, research by Talogy finds
65% of hiring managers are concerned about candidates using Gen AI such as ChatGPT to ‘cheat’ on recruitment assessments However, only 15% of early career... Read more.
ThroughPut.AI Launches Catalyst Program to Accelerate AI-Driven Supply Chain Transformation for Businesses Without Buying More Tools
Program aimed at helping businesses unlock rapid results from their existing tech stack – no new integrations, no delays, just immediately actionable insights... Read more.
Coconut Software Partners with National Bank to Innovate Client Access, Achieve 3x Remote Booking Growth
SASKATOON, SK and MONTREAL, June 5, 2025 /PRNewswire/ – Coconut Software, a leading provider of appointment scheduling and lobby management solutions, today... Read more.
REGENXBIO REPORTS NEW POSITIVE FUNCTIONAL DATA FROM PHASE I/II AFFINITY DUCHENNE® TRIAL OF RGX-202
RGX-202 demonstrating consistent evidence of positively changing disease trajectory for Duchenne All dose level 2 participants exceeded external natural history... Read more.
Metalpha Partners with DogeOS to Expand Crypto Innovation and Promote Dogecoin’s Vision
Strategic Alliance Combines MyDoge’s Retail Legacy with Institutional Expertise to Drive DOGE Innovation HONG KONG, June 5, 2025 /PRNewswire/ —... Read more.
Zywave Announces Inaugural Digital Distribution Insights Conference
Exclusive event will unite insurance industry thought leaders, providers, and brokers to explore strategies for driving premium growth in an increasingly complex... Read more.